Endara M, Masden D, Goldstein J, Gondek S, Steinberg J, Attinger C. The role of chronic and perioperative glucose management in high-risk surgical closures: a case for tighter glycemic control. Plast Reconstr Surg. 2013;132(4):996–1004. PMID: 23783058. https://doi.org/10.1097/PRS.0b013e31829fe119.
Wyld M, Morton RL, Hayen A, Howard K, Webster AC. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med. 2012;9(9):e1001307. https://doi.org/10.1371/journal.pmed.1001307. Epub 2012 Sep 11. PMID: 22984353; PMCID: PMC3439392.
Zhang L, Guo Y, Ming H. Effects of hemodialysis, peritoneal dialysis, and renal transplantation on the quality of life of patients with end-stage renal disease. Rev Assoc Med Bras (1992). 2020;66(9):1229–1234. PMID: 33027450. https://doi.org/10.1590/1806-9282.66.9.1229.
Fockens MM, Alberts VP, Bemelman FJ, van der Pant KA, Idu MM. Wound morbidity after kidney transplant. Prog Transplant. 2015;25(1):45 – 8. PMID: 25758800. https://doi.org/10.7182/pit2015812.
Wong RBK, Minkovich M, Famure O, Li Y, Lee JY, Selzner M, Kim SJ, Ghanekar A. Surgical site complications in kidney transplant recipients: incidence, risk factors and outcomes in the modern era. Can J Surg. 2021;64(6):E669–76. https://doi.org/10.1503/cjs.015820. PMID: 34933944; PMCID: PMC8711553.
Kuo JH, Wong MS, Perez RV, Li CS, Lin TC, Troppmann C. Renal transplant wound complications in the modern era of obesity. J Surg Res. 2012;173(2):216–23. https://doi.org/10.1016/j.jss.2011.05.030. Epub 2011 Jul 13. PMID: 21816424.
Lau NS, Ahmadi N, Verran D. Abdominal wall complications following renal transplantation in adult recipients – factors associated with interventional management in one unit. BMC Surg. 2019;19(1):10. https://doi.org/10.1186/s12893-019-0468-x. PMID: 30665387; PMCID: PMC6341541.
Peluso G, Incollingo P, Campanile S, Menkulazi M, Scotti A, Tammaro V, Calogero A, Dodaro C, Carlomagno N, Santangelo ML. Relation between wound complication and lymphocele after kidney transplantation: a monocentric study. Transplant Proc. 2020;52(5):1562–1565. https://doi.org/10.1016/j.transproceed.2020.02.053. Epub 2020 Apr 14. PMID: 32299707.
Alonso M, Villanego F, Vigara LA, Aguilera A, RuÃz E, GarcÃa A, Montero ME, MÃnguez MC, Garcia-Baquero R, GarcÃa T, Mazuecos A. Surgical wound dehiscence in kidney transplantation: risk factors and impact on graft survival. Transplant Proc. 2022;54(1):27–31. https://doi.org/10.1016/j.transproceed.2021.09.066. Epub 2021 Dec 5. PMID: 34876270.
Røine E, Bjørk IT, Oyen O. Targeting risk factors for impaired wound healing and wound complications after kidney transplantation. Transplant Proc. 2010;42(7):2542-6. PMID: 20832540. https://doi.org/10.1016/j.transproceed.2010.05.162.
Mehrabi A, Fonouni H, Wente M, et al. Wound complications following kidney and liver transplantation. Clin Transpl. 2006;20Suppl 17:97–110. https://doi.org/10.1111/j.1399-0012.2006.00608.x.
Murdoch DM, Venter WD, Van Rie A, Feldman C. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS ResTher. 2007;4:9. https://doi.org/10.1186/1742-6405-4-9.
Sun HY, Singh N. Opportunistic infection-associated immune reconstitution syndrome in transplant recipients. ClinInfectDis. 2011;53(2):168–76. https://doi.org/10.1093/cid/cir276.
Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8(8):516–23. https://doi.org/10.1016/S1473-3099(08)70184-1.
McLin VA, Belli DC, Posfay-Barbe KM. Immune reconstitution inflammatory syndrome and solid organ transplant recipients: are children protected? Pediatr Transpl. 2010;14(1):19–22. https://doi.org/10.1111/j.1399-3046.2009.01265.x.
Ghosh N, Kolade OO, Shontz E, et al. Nonsteroidal anti-inflammatory drugs (NSAIDs) and their effect on musculoskeletal soft-tissue healing: a scoping review. JBJS Rev. 2019;7(12):e4. https://doi.org/10.2106/JBJS.RVW.19.00055.
Schug SA. Do NSAIDs really interfere with healing after surgery? J ClinMed. 2021;10(11):2359. https://doi.org/10.3390/jcm10112359.
Hertel J. The role of nonsteroidal anti-inflammatory drugs in the treatment of acute soft tissue injuries. J AthlTrain. 1997;32(4):350–8.
Zhao-Fleming H, Hand A, Zhang K, et al. Effect of non-steroidal anti-inflammatory drugs on post-surgical complications against the backdrop of the opioid crisis. BurnsTrauma. 2018;6:25. https://doi.org/10.1186/s41038-018-0128-x.
Baron C, Forconi C, Lebranchu Y. Revisiting the effects of CMV on long-term transplant outcome. CurrOpinOrganTransplant. 2010;15(4):492–8. https://doi.org/10.1097/MOT.0b013e32833bd3b5.
Roman A, Manito N, Campistol JM, et al. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients. TransplantRev (Orlando). 2014;28(2):84–91. https://doi.org/10.1016/j.trre.2014.01.001.
Dasari N, Jiang A, Skochdopole A, et al. Updates in diabetic wound healing, inflammation, and scarring. SeminPlastSurg. 2021;35(3):153–8. https://doi.org/10.1055/s-0041-1731460.
Endara M, Masden D, Goldstein J, et al. The role of chronic and perioperative glucose management in high-risk surgical closures: a case for tighter glycemic control. PlastReconstrSurg. 2013;132(4):996–1004. https://doi.org/10.1097/PRS.0b013e31829fe119.
Martin ET, Kaye KS, Knott C, et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. InfectControlHospEpidemiol. 2016;37(1):88–99. https://doi.org/10.1017/ice.2015.249.